EUVIMEDOpdag EUVIMED
Open access · CC BY-NC-ND 4.0

Comprehensive Analysis Identified and Validated CX3CR1 as Potential Biomarkers for Atherosclerosis

Hongxuan Li, Xin Liu, Yanhui Cen, Wei Jia, Bojia Li, Xiaoying Qu, Qiyan Jin

Frontiers in Biotechnology and Genetics · 2025-12-11 · 2 (1) · 51-78

DOI: 10.71465/fbg483 ↗

At a glance

Journal article in Frontiers in Biotechnology and Genetics, published online on 2025-12-11. Written by Hongxuan Li and 6 co-authors. The full text is freely available (open access, CC BY-NC-ND 4.0).

AbstractBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Background

The etiology and disease development of atherosclerosis (AS) are still incompletely understood. In this research, we try to identify the gene biomarkers that play roles in the development and progression of AS and the relationship with immune cells.

Methods

By mining Gene Expression Omnibus (GEO) database, we acquired the dataset of AS for further research. After identifying the differentially expressed genes (DEGs) shared by AS and normal control samples, we performed functional enrichment analysis to them. Integrating the least absolute shrinkage and selection operator (LASSO) algorithm, support vector machine recursive feature elimination (SVM-RFE) algorithm, and random forest (RF) algorithm we ultimately selected genes candidates for the development of AS. Using CIBERSORT method, the difference of the immune infiltration of AS and normal control samples were analyzed. We also investigate the correlation of optimal gene biomarkers and specific several types of immune cells.

Results

DEGs were involved in the Toll-like receptor signaling pathways and Leukocyte transendothelial migration. Results of Gene Ontology (GO) analysis showed significant enrichment of DEGs in regulation of inflammatory response, leukocyte migration, and immune receptor activity. While Disease Ontology (DO) analysis indicated that DEGs are significantly enriched in terms including lung disease, atherosclerosis, coronary artery disease, and arteriosclerosis. CX3CR1 and C3 were screened by the LASSO, SVM-REF, and RF algorithms. AS samples showed relatively low infiltration levels of naive B cells (P

Cite

APA

Li, H., Liu, X., Cen, Y., Jia, W., Li, B., Qu, X., & Jin, Q. (2025). Comprehensive Analysis Identified and Validated CX3CR1 as Potential Biomarkers for Atherosclerosis. Frontiers in Biotechnology and Genetics, 2(1), 51-78. https://doi.org/10.71465/fbg483

Vancouver

Li H, Liu X, Cen Y, Jia W, Li B, Qu X, et al. Comprehensive Analysis Identified and Validated CX3CR1 as Potential Biomarkers for Atherosclerosis. Frontiers in Biotechnology and Genetics. 2025;2(1):51-78. doi:10.71465/fbg483

BibTeX
@article{Li2025,
  author = {Li, Hongxuan and Liu, Xin and Cen, Yanhui and Jia, Wei and Li, Bojia and Qu, Xiaoying and Jin, Qiyan},
  title = {Comprehensive Analysis Identified and Validated CX3CR1 as Potential Biomarkers for Atherosclerosis},
  journal = {Frontiers in Biotechnology and Genetics},
  year = {2025},
  volume = {2},
  number = {1},
  pages = {51--78},
  doi = {10.71465/fbg483}
}
Start for free →